BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18094649)

  • 1. Molecular classification of thyroid nodules by cytology.
    Pagedar NA; Chen DH; Wasman JK; Savvides P; Schluchter MD; Wilhelm SM; Lavertu P
    Laryngoscope; 2008 Apr; 118(4):692-6. PubMed ID: 18094649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens.
    Giannini R; Faviana P; Cavinato T; Elisei R; Pacini F; Berti P; Fontanini G; Ugolini C; Camacci T; De Ieso K; Miccoli P; Pinchera A; Basolo F
    Thyroid; 2003 Aug; 13(8):765-70. PubMed ID: 14558920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in indeterminate specimens.
    Kelman AS; Rathan A; Leibowitz J; Burstein DE; Haber RS
    Thyroid; 2001 Mar; 11(3):271-7. PubMed ID: 11327619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
    Saggiorato E; Aversa S; Deandreis D; Arecco F; Mussa A; Puligheddu B; Cappia S; Conticello S; Papotti M; Orlandi F
    J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms.
    Liou MJ; Chan EC; Lin JD; Liu FH; Chao TC
    Cancer Lett; 2003 Mar; 191(2):223-7. PubMed ID: 12618337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.
    Bartolazzi A; Orlandi F; Saggiorato E; Volante M; Arecco F; Rossetto R; Palestini N; Ghigo E; Papotti M; Bussolati G; Martegani MP; Pantellini F; Carpi A; Giovagnoli MR; Monti S; Toscano V; Sciacchitano S; Pennelli GM; Mian C; Pelizzo MR; Rugge M; Troncone G; Palombini L; Chiappetta G; Botti G; Vecchione A; Bellocco R;
    Lancet Oncol; 2008 Jun; 9(6):543-9. PubMed ID: 18495537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase activity in "suspicious" thyroid cytology.
    Lerma E; Mora J
    Cancer; 2005 Dec; 105(6):492-7. PubMed ID: 16104043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human telomerase reverse transcriptase expression in Diff-Quik-stained FNA samples from thyroid nodules.
    Siddiqui MT; Greene KL; Clark DP; Xydas S; Udelsman R; Smallridge RC; Zeiger MA; Saji M
    Diagn Mol Pathol; 2001 Jun; 10(2):123-9. PubMed ID: 11385322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of galectin-3 messenger ribonucleic Acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction.
    Bernet VJ; Anderson J; Vaishnav Y; Solomon B; Adair CF; Saji M; Burman KD; Burch HB; Ringel MD
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4792-6. PubMed ID: 12364475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of TTF-1 in thyroid tumors originating from follicular epithelium and its correlation with expression of RET, galectin-3 and mucin-1 genes].
    Chen Y; Zhu M; Zhou X; Lin W; Ni C; Li F; Zhang S; Gong Z
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):257-61. PubMed ID: 11953175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis.
    Borrelli N; Ugolini C; Giannini R; Antonelli A; Giordano M; Sensi E; Torregrossa L; Fallahi P; Miccoli P; Basolo F
    Cancer Cytopathol; 2016 May; 124(5):340-9. PubMed ID: 26749005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and clinical significance of galectin-3 in well-differentiated thyroid carcinoma].
    Ouyang D; Chen FJ; Wei MW; Yang AK; Chen ZQ; Li QL; Chen YF
    Ai Zheng; 2005 Nov; 24(11):1367-71. PubMed ID: 16552965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMGA2 expression analysis in cytological and paraffin-embedded tissue specimens of thyroid tumors by relative quantitative RT-PCR.
    Jin L; Lloyd RV; Nassar A; Lappinga PJ; Sebo TJ; Swartz K; Seys AR; Erickson-Johnson MR; Roth CW; Evers BR; Oliveira AM; Zhang J
    Diagn Mol Pathol; 2011 Jun; 20(2):71-80. PubMed ID: 21532495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine-needle aspiration biopsy-RT-PCR expression analysis of prothymosin alpha and parathymosin in thyroid: novel proliferation markers?
    Letsas KP; Vartholomatos G; Tsepi C; Tsatsoulis A; Frangou-Lazaridis M
    Neoplasma; 2007; 54(1):57-62. PubMed ID: 17203893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Elasticity of Thyroid Nodules on Ultrasound Elastography Is Correlated with Malignancy, Degree of Fibrosis, and High Expression of Galectin-3 and Fibronectin-1.
    Rago T; Scutari M; Loiacono V; Santini F; Tonacchera M; Torregrossa L; Giannini R; Borrelli N; Proietti A; Basolo F; Miccoli P; Piaggi P; Latrofa F; Vitti P
    Thyroid; 2017 Jan; 27(1):103-110. PubMed ID: 27809694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of follicular neoplasm in thyroid nodules by fine needle aspiration cytology: does the result, benign vs. suspicious for a malignant process, in these nodules make a difference?
    Marhefka GD; McDivitt JD; Shakir KM; Drake AJ
    Acta Cytol; 2009; 53(5):517-23. PubMed ID: 19798878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms.
    Inohara H; Honjo Y; Yoshii T; Akahani S; Yoshida J; Hattori K; Okamoto S; Sawada T; Raz A; Kubo T
    Cancer; 1999 Jun; 85(11):2475-84. PubMed ID: 10357421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules.
    Kim SK; Kim DL; Han HS; Kim WS; Kim SJ; Moon WJ; Oh SY; Hwang TS
    Diagn Mol Pathol; 2008 Jun; 17(2):118-25. PubMed ID: 18382358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One in four patients with follicular thyroid cytology (THY3) has a thyroid carcinoma.
    Mihai R; Parker AJ; Roskell D; Sadler GP
    Thyroid; 2009 Jan; 19(1):33-7. PubMed ID: 18976164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.